Manuela Valente
Known title: Chief People OfficerCIK: 0002009280
Associated companies
Transaction History
| SOPH | ▲ Buy | Option Exercise | 10,000 | $32K | 8/19/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 10,000 | $79K | 8/19/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 4,241 | $21K | 7/6/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 380 | $2K | 5/19/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 380 | $2K | 4/20/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 3,824 | $19K | 4/8/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 2,376 | $12K | 4/7/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 2,597 | $13K | 4/6/2026 | View on chart |
| SOPH | ▲ Buy | Grant | 71,869 | $0 | 4/2/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 380 | $2K | 3/19/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
SOPHiA GENETICS Shares Rise 7% Amid Questions on Momentum
Shares of SOPHiA GENETICS climbed 7% in early trading, pushing the stock toward the upper end of its 52‑week range. The move comes with an RSI of 55.5, indicating moderate momentum, and the stock remains above the $4.85 support level that has been tested 13 times. Analysts keep a target of $9.75, but the recent gain raises questions about how long the upward trend can continue.
SOPHiA GENETICS Shares Rise 7% Amid Questions on Momentum. Shares of SOPHiA GENETICS climbed 7% in early trading, pushing the stock toward the upper end of its 52‑week range. The move comes with an RSI of 55.5, indicating moderate momentum, and the stock remains above the $4.85 support level that has been tested 13 times. Analysts keep a target of $9.75, but the recent gain raises questions about how long the upward trend can continue.